Cargando…
Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185090/ https://www.ncbi.nlm.nih.gov/pubmed/25280736 http://dx.doi.org/10.3402/gha.v7.24795 |
_version_ | 1782337944543035392 |
---|---|
author | Tabatabai, Julia Namakhoma, Ireen Tweya, Hannock Phiri, Sam Schnitzler, Paul Neuhann, Florian |
author_facet | Tabatabai, Julia Namakhoma, Ireen Tweya, Hannock Phiri, Sam Schnitzler, Paul Neuhann, Florian |
author_sort | Tabatabai, Julia |
collection | PubMed |
description | BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the prevention of temporary/permanent loss of patients in care. Understanding reasons for treatment interruption (TI) can inform strategies for improving drug adherence and retention in care. OBJECTIVE: To evaluate key characteristics of patients resuming ART after TI at the Lighthouse Clinic in Lilongwe, Malawi, and to identify their reasons for interrupting ART. DESIGN: This study uses a mixed methods design to evaluate patients resuming ART after TI. We analysed an assessment form for patients with TI using pre-defined categories and a comments field to identify frequently stated reasons for TI. Additionally, we conducted 26 in-depth interviews to deepen our understanding of common reasons for TI. In-depth interviews also included the patients’ knowledge about ART and presence of social support systems. Qualitative data analysis was based on a thematic framework approach. RESULTS: A total of 347 patients (58.2% female, average age 35.1±11.3 years) with TI were identified. Despite the presence of social support and sufficient knowledge of possible consequences of TI, all patients experienced situations that resulted in TI. Analysis of in-depth interviews led to new and distinct categories for TI. The most common reason for TI was travel (54.5%, n=80/147), which further differentiated into work- or family-related travel. Patients also stated transport costs and health-care-provider-related reasons, which included perceived/enacted discrimination by health care workers. Other drivers of TI were treatment fatigue/forgetfulness, the patients’ health status, adverse drug effects, pregnancy/delivery, religious belief or perceived/enacted stigma. CONCLUSIONS: To adequately address patients’ needs on a lifelong therapy, adherence-counselling sessions require provision of problem-solving strategies for common barriers to continuous care. |
format | Online Article Text |
id | pubmed-4185090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Co-Action Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-41850902014-10-14 Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi Tabatabai, Julia Namakhoma, Ireen Tweya, Hannock Phiri, Sam Schnitzler, Paul Neuhann, Florian Glob Health Action Original Article BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the prevention of temporary/permanent loss of patients in care. Understanding reasons for treatment interruption (TI) can inform strategies for improving drug adherence and retention in care. OBJECTIVE: To evaluate key characteristics of patients resuming ART after TI at the Lighthouse Clinic in Lilongwe, Malawi, and to identify their reasons for interrupting ART. DESIGN: This study uses a mixed methods design to evaluate patients resuming ART after TI. We analysed an assessment form for patients with TI using pre-defined categories and a comments field to identify frequently stated reasons for TI. Additionally, we conducted 26 in-depth interviews to deepen our understanding of common reasons for TI. In-depth interviews also included the patients’ knowledge about ART and presence of social support systems. Qualitative data analysis was based on a thematic framework approach. RESULTS: A total of 347 patients (58.2% female, average age 35.1±11.3 years) with TI were identified. Despite the presence of social support and sufficient knowledge of possible consequences of TI, all patients experienced situations that resulted in TI. Analysis of in-depth interviews led to new and distinct categories for TI. The most common reason for TI was travel (54.5%, n=80/147), which further differentiated into work- or family-related travel. Patients also stated transport costs and health-care-provider-related reasons, which included perceived/enacted discrimination by health care workers. Other drivers of TI were treatment fatigue/forgetfulness, the patients’ health status, adverse drug effects, pregnancy/delivery, religious belief or perceived/enacted stigma. CONCLUSIONS: To adequately address patients’ needs on a lifelong therapy, adherence-counselling sessions require provision of problem-solving strategies for common barriers to continuous care. Co-Action Publishing 2014-09-30 /pmc/articles/PMC4185090/ /pubmed/25280736 http://dx.doi.org/10.3402/gha.v7.24795 Text en © 2014 Julia Tabatabai et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Tabatabai, Julia Namakhoma, Ireen Tweya, Hannock Phiri, Sam Schnitzler, Paul Neuhann, Florian Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title | Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title_full | Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title_fullStr | Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title_full_unstemmed | Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title_short | Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi |
title_sort | understanding reasons for treatment interruption amongst patients on antiretroviral therapy – a qualitative study at the lighthouse clinic, lilongwe, malawi |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185090/ https://www.ncbi.nlm.nih.gov/pubmed/25280736 http://dx.doi.org/10.3402/gha.v7.24795 |
work_keys_str_mv | AT tabatabaijulia understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi AT namakhomaireen understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi AT tweyahannock understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi AT phirisam understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi AT schnitzlerpaul understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi AT neuhannflorian understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi |